UBE2C and non-small cell lung carcinoma: Furthermore, to evaluate whether UBE2C was involved in regulating progression of NSCLC, SLIT3-silenced A549/NCI-H1299 cells were treated with siRNA (UBE2C) for 48 h (Figure 2f).